Home Cart Sign in  
Chemical Structure| 155148-31-5 Chemical Structure| 155148-31-5

Structure of Plerixafor octahydrochloride
CAS No.: 155148-31-5

Chemical Structure| 155148-31-5

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Plerixafor octaHCl is a CXCR4 antagonist that mobilizes hematopoietic stem cells. Plerixafor octaHCl is primarily used in stem cell transplantation and research on HIV infection.

Synonyms: AMD3100 octahydrochloride; JM3100 octahydrochloride; Plerixafor 8HCl

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Plerixafor octahydrochloride

CAS No. :155148-31-5
Formula : C28H62Cl8N8
M.W : 794.47
SMILES Code : [H]Cl.[H]Cl.[H]Cl.[H]Cl.[H]Cl.[H]Cl.[H]Cl.[H]Cl.C1(CN2CCNCCCNCCNCCC2)=CC=C(CN3CCNCCCNCCNCCC3)C=C1
Synonyms :
AMD3100 octahydrochloride; JM3100 octahydrochloride; Plerixafor 8HCl
MDL No. :MFCD04974488
InChI Key :UEUPDYPUTTUXLJ-UHFFFAOYSA-N
Pubchem ID :65014

Safety of Plerixafor octahydrochloride

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302
Precautionary Statements:P280-P305+P351+P338

Related Pathways of Plerixafor octahydrochloride

GPCR

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description References
EJ cells 50 μM 24 h To evaluate the effect of Plerixafor on the CXCR4 downstream signaling pathway, results showed that Plerixafor significantly inhibited the phosphorylation of Erk and Akt PMC9977173
KU812F cells 50 μM 3 h Plerixafor reduced the adhesion of CML cells to bone marrow microenvironment components PMC4124489
KU812F cells 50 μM 3 h Plerixafor inhibited the chemotactic response of CML cells to SDF1 PMC4124489
KU812F cells 50 μM 3 h Plerixafor inhibited the trans-endothelial migration of CML cells PMC4124489
KU812F cells 50 μM 3 h Plerixafor reversed the protective effect of bone marrow stromal cells and re-sensitized CML cells to nilotinib PMC4124489
MDA-MB-231 cells 10 μg/mL 1 h To study the uptake of Plerixafor-modified nanocarriers in CXCR4-expressing cells, results showed that Plerixafor-modified carriers were uptaken at a higher rate in CXCR4-expressing cells compared to unmodified carriers. PMC5474759

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
Mice Whole body irradiation (WBI) and skin irradiation (SI) model Subcutaneous injection 5 mg/kg Single injection, administered on day 6 To evaluate the effect of Plerixafor in combination with G-CSF on MSC-FMB in correcting radiation-induced wound healing deficits, results showed that Plerixafor enhanced the efficacy of MSC-FMB. PMC3519961
Mice Spinal cord injury model Subcutaneous injection 5 mg/kg Once daily for 3 days Plerixafor effectively liberates HSPCs and mature leukocytes from the bone marrow of SCI mice, partly reversing bone marrow failure. PMC7382469
BALB/c nude mice EJ xenograft model Intravenous injection 500 μM, 100 μl Once every 2 days for a total of five times To evaluate the effect of Plerixafor on tumor growth, results showed that Plerixafor significantly inhibited tumor growth PMC9977173
Rhesus macaques Gene therapy model Intravenous injection 1 mg/kg Single dose, on day 5 Used to mobilize CD34+ cells for gene therapy PMC10570335
Mice BCR-ABL-positive leukemia mouse model Subcutaneous injection 5 mg/kg Once daily for 10 days Plerixafor in combination with nilotinib significantly prolonged survival and reduced leukemia burden in mice PMC4124489

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

1.26mL

0.25mL

0.13mL

6.29mL

1.26mL

0.63mL

12.59mL

2.52mL

1.26mL

 

Historical Records

Categories